Nama's AI scorecard currently rates Cigna Group Buy (6.0 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is CI's P/E ratio?

Cigna Group trades at a trailing price-to-earnings ratio of 9.3.

When does CI report earnings?

Cigna Group's next scheduled report is on Feb 4, 2027. Analysts expect EPS of $7.30.

What is the CI price target?

The median analyst price target from 24 analysts is $345.00, with a range of $288.00 – $400.00.

Is CI Shariah compliant?

Nama's AAOIFI-style screen reads Cigna Group as Not Shariah Compliant. At least one of the three ratios or the industry test failed.

Does CI pay a dividend?

Yes — Cigna Group's dividend yield is 2.1%.

Nama Insights

Cigna Group (CI)

Healthcare · Healthcare Plans · NYSE

S&P 500

Cigna Group (CI) is a Healthcare company in the Healthcare Plans industry. It has a market capitalization of $77.58B, a trailing price-to-earnings ratio of 9.3 and a free-cash-flow yield of 10.6%. Over the most recent reported fiscal year, revenue grew 11.3% and free cash flow per share fell 1.2%. Nama's AI scorecard rates it Buy, 6.0 out of 10. On 12-month momentum it ranks in the rising band of its market.

AI scorecard

Buy · 6.0/10

Positive, at the low end of Buy. As of Nov 7, 2026.

Momentum

Rising · +8.6% over 12 months ex. last

Second-best fifth of its market on the past year's move.

Shariah screen

Not Shariah Compliant

At least one of the three ratios or the industry test failed.

Off its high

-20.8%

How far the last close sits under the highest price of the past five years.

Market cap	$77.58B
Trailing P/E	9.3
Price / book	1.8
Price / sales	0.3
FCF yield	10.6%
Dividend yield	2.1%
Gross margin	8.8%
Operating margin	3.2%
Net margin	2.3%
Revenue growth (YoY)	+11.3%
Revenue growth (3-yr annual)	+15.2%
EPS growth (YoY)	+9.2%
FCF/share growth (YoY)	-1.2%
Beta	0.3
Exchange	NYSE
Sector	Healthcare
Industry	Healthcare Plans

CI earnings

Next report: Feb 4, 2027 (Q4 2026, EPS estimate $7.30). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Nov 5, 2026	$7.98	$7.51	+6.3%	—
Q2 2026	Jul 30, 2026	$7.78	$7.60	+2.4%	$71.40B
Q1 2026	Apr 30, 2026	$7.79	$7.61	+2.4%	$68.29B
Q4 2025	Feb 5, 2026	$8.08	$7.88	+2.5%	$72.13B

CI analyst price target

Median target $345.00 from 24 analysts, ranging $288.00 – $400.00.

Healthcare Plans peers

Ticker	Company	Market cap	P/E
UNH	UnitedHealth Group	$353.17B	19.3
CVS	CVS Health	$107.28B	10.1
ELV	Elevance Health	$91.96B	14.0
HUM	Humana	$52.08B	32.7
CNC	Centene	$34.53B	13.2
MOH	Molina Healthcare	$10.87B	104.5
OSCR	Oscar Health	$9.46B	12.7
PGNY	Progyny	$2.58B	17.0

Explore live CI data on Nama Insights →

Recent Congressional trades

Cigna Group trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Julie Johnson	House	Buy	$1,001 - $15,000	Aug 5, 2026
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
Jared Moskowitz	House	Sell	$1,001 - $15,000	Apr 30, 2026
Julie Johnson	House	Sell	$1,001 - $15,000	Jan 15, 2026
Julia Letlow	House	Buy	$1,001 - $15,000	Jan 13, 2026
Julie Johnson	House	Sell	$1,001 - $15,000	Dec 11, 2025
Valerie Hoyle	House	Sell	$1,001 - $15,000	Oct 10, 2025
Julie Johnson	House	Sell	$1,001 - $15,000	Oct 7, 2025
Gilbert Cisneros	House	Sell	$1,001 - $15,000	Sep 12, 2025
Valerie Hoyle	House	Buy	$1,001 - $15,000	Sep 12, 2025
Julie Johnson	House	Sell	$1,001 - $15,000	Sep 11, 2025
Jared Moskowitz	House	Buy	$1,001 - $15,000	Jun 27, 2025

CI FAQ

Is CI a buy?: Nama's AI scorecard currently rates Cigna Group Buy (6.0 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is CI's P/E ratio?: Cigna Group trades at a trailing price-to-earnings ratio of 9.3.
When does CI report earnings?: Cigna Group's next scheduled report is on Feb 4, 2027. Analysts expect EPS of $7.30.
What is the CI price target?: The median analyst price target from 24 analysts is $345.00, with a range of $288.00 – $400.00.
Is CI Shariah compliant?: Nama's AAOIFI-style screen reads Cigna Group as Not Shariah Compliant. At least one of the three ratios or the industry test failed.
Does CI pay a dividend?: Yes — Cigna Group's dividend yield is 2.1%.